Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of TWP-201 in Healthy Female Subjects
NCT04878705Phase 1Unknown
- Sponsor
- Therawisdom Biopharma
- Start
- May 2021
- Primary completion
- Oct 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in infertility comparing TWP-201 with Placebo (2 arms). Primary endpoint: Incidence of adverse events, serious adverse and abnormal laboratory values event at 1 year. Status: unknown.
02
Drugs
TWP-201
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04878705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04878705.